Similar articles for PMID: 22582980

Year	Number of Results
2003	1
2004	2
2005	4
2006	4
2007	1
2008	4
2009	10
2010	8
2011	14
2012	11
2013	12
2014	6
2015	4
2016	2
2017	5
2018	8
2019	7
2020	2
2021	6
2022	1
2023	1
2024	0

1

Genetic predisposition to atorvastatin-induced myopathy: a case report.

Francesca Notarangelo M, Marziliano N, Antonietta Demola M, Pigazzani F, Guidorossi A, Angelica Merlini P, Ardissino D. Francesca Notarangelo M, et al. J Clin Pharm Ther. 2012 Oct;37(5):604-6. doi: 10.1111/j.1365-2710.2012.01337.x. Epub 2012 May 14. J Clin Pharm Ther. 2012. PMID: 22582980

2

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.

Brunham LR, Lansberg PJ, Zhang L, Miao F, Carter C, Hovingh GK, Visscher H, Jukema JW, Stalenhoef AF, Ross CJ, Carleton BC, Kastelein JJ, Hayden MR. Brunham LR, et al. Pharmacogenomics J. 2012 Jun;12(3):233-7. doi: 10.1038/tpj.2010.92. Epub 2011 Jan 18. Pharmacogenomics J. 2012. PMID: 21243006

3

SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.

Hubáček JA, Dlouhá D, Adámková V, Zlatohlavek L, Viklický O, Hrubá P, Češka R, Vrablík M. Hubáček JA, et al. Med Sci Monit. 2015 May 20;21:1454-9. doi: 10.12659/MSM.893007. Med Sci Monit. 2015. PMID: 25992810 Free PMC article.

4

Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy.

Hermann M, Bogsrud MP, Molden E, Asberg A, Mohebi BU, Ose L, Retterstøl K. Hermann M, et al. Clin Pharmacol Ther. 2006 Jun;79(6):532-9. doi: 10.1016/j.clpt.2006.02.014. Clin Pharmacol Ther. 2006. PMID: 16765141

5

The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study.

de Keyser CE, Peters BJ, Becker ML, Visser LE, Uitterlinden AG, Klungel OH, Verstuyft C, Hofman A, Maitland-van der Zee AH, Stricker BH. de Keyser CE, et al. Pharmacogenet Genomics. 2014 Jan;24(1):43-51. doi: 10.1097/FPC.0000000000000018. Pharmacogenet Genomics. 2014. PMID: 24263182

6

Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy.

Danik JS, Chasman DI, MacFadyen JG, Nyberg F, Barratt BJ, Ridker PM. Danik JS, et al. Am Heart J. 2013 Jun;165(6):1008-14. doi: 10.1016/j.ahj.2013.01.025. Epub 2013 Apr 10. Am Heart J. 2013. PMID: 23708174 Clinical Trial.

7

The SLCO1B1*5 genetic variant is associated with statin-induced side effects.

Voora D, Shah SH, Spasojevic I, Ali S, Reed CR, Salisbury BA, Ginsburg GS. Voora D, et al. J Am Coll Cardiol. 2009 Oct 20;54(17):1609-16. doi: 10.1016/j.jacc.2009.04.053. J Am Coll Cardiol. 2009. PMID: 19833260 Free PMC article. Clinical Trial.

8

The genetics of statin-induced myopathy.

Ghatak A, Faheem O, Thompson PD. Ghatak A, et al. Atherosclerosis. 2010 Jun;210(2):337-43. doi: 10.1016/j.atherosclerosis.2009.11.033. Epub 2009 Nov 27. Atherosclerosis. 2010. PMID: 20042189 Review.

9

Possible gene-gender interaction between the SLCO1B1 polymorphism and statin treatment efficacy.

Hubacek JA, Dlouha D, Adámkova V, Lanska V, Ceska R, Vrablik M. Hubacek JA, et al. Neuro Endocrinol Lett. 2012;33 Suppl 2:22-5. Neuro Endocrinol Lett. 2012. PMID: 23183505

10

Marusic S, Lisicic A, Horvatic I, Bacic-Vrca V, Bozina N. Marusic S, et al. Int J Clin Pharm. 2012 Dec;34(6):825-7. doi: 10.1007/s11096-012-9717-0. Epub 2012 Oct 18. Int J Clin Pharm. 2012. PMID: 23076661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year